KELLY PLONSKI: Open Payments
NPI 1003461351 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 11 payments from 7 companies in 2025. Trend: 2023 $664 · 2024 $1,791 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $370 |
| E.R. Squibb & Sons, L.L.C. | 2 | $246 |
| Xeris Pharmaceuticals, Inc. | 2 | $219 |
| SANOFI-AVENTIS U.S. LLC | 1 | $162 |
| GlaxoSmithKline, LLC. | 1 | $106 |
| GENZYME CORPORATION | 1 | $104 |
| Boston Scientific Corporation | 1 | $19 |
Products named: TEPEZZA, ZEPOSIA, GVOKE HYPOPEN, NUCALA, RECORLEV, WATCHMAN FLX.
Industry payments across OH — which companies pay providers there.
